CONMED Brand Guidelines: A 1970 Utica Distributor, an ECG Electrode & a Move to Largo

A distributor in Utica and a disposable electrode.

CONMED began in Utica, New York, in 1970. English Wikipedia says Eugene Corasanti bought a small medical supplies distributor there that year, first calling the business Concor Enterprises and later renaming it Consolidated Medical Equipment, Inc., the source of the shortened name. The company’s own retelling, published on its blog for its 56th year, describes a start “on a tiny kitchen counter” and a distributor working out of a single building in Utica.

Its first product, both Wikipedia and the company say, was a disposable ECG electrode — the sticky sensor pad used to record the heart’s electrical signal. The company dates that electrode to 1973 on its history page. Through the late 1970s and the 1980s, the company says, it added the Aspen line of electrosurgical generators, which it calls its first proprietary surgical product; Wikipedia lists the purchase of Aspen Labs from Bristol-Myers Squibb in 1989. CONMED says it went public on the NASDAQ in 1987.

The 1990s were a run of purchases. The company lists the Concept electrosurgical disposables business in 1991 and Medtronic Andover Medical in 1993. In January 1995 the Los Angeles Times reported that Conmed, then described as a New York-based competitor, had proposed a merger with Birtcher Medical Systems of Irvine, California, and that analysts saw its interest in Birtcher’s electrosurgical products and its contract manufacturing operation across the border in Juárez, Mexico. Wikipedia lists Birtcher, maker of the Hyfrecator, among the 1995 acquisitions, along with New Dimensions in Medicine.

Linvatec, Hall and the operating theatre.

The purchase that reshaped the company came in 1997, when CONMED bought Linvatec from Bristol-Myers Squibb, as Wikipedia records. CONMED says the deal more than doubled its size and brought an international presence in arthroscopy and powered surgical instruments, including the Hall power-tool name, which the company’s blog describes as already trusted by orthopaedic surgeons; the same post calls the Linvatec purchase “the deal that doubled everything overnight.” From that point the company presented itself less as an electrode maker and more as a supplier to the orthopaedic operating theatre: arthroscopy shavers, suture anchors, power drills and saws, and camera systems for keyhole surgery.

The company credits itself with several “firsts” from that line, among them the Surgairtome, which it calls the first high-speed pneumatic drill; the Concept shaver blade, which it calls the first single-use arthroscopic shaver blade; and the Y-Knot RC, which it calls the first self-punching all-suture anchor. These are the company’s own descriptions. Its sports medicine range today also includes the Argo Knotless suture anchor, Wikipedia notes, and an allograft tissue agreement with the Musculoskeletal Transplant Foundation that CONMED dates to 2011.

Later acquisitions widened the range beyond orthopaedics. Wikipedia lists Bionx Implants in 2003; the endoscopic unit of C.R. Bard in 2004, which the company describes as most of Bard’s gastroenterology and pulmonary business; Viking Systems, a 3D visualisation company, in 2012; and the ExoShape ACL line from MedShape in 2017. In 2016 CONMED bought SurgiQuest and with it the AirSeal insufflation system used in laparoscopic surgery, and in 2019 it bought Buffalo Filter, a maker of surgical smoke evacuation equipment.

In 2022 two more deals brought it back toward orthopaedics: In2Bones, a foot-and-ankle and upper-extremity implant company now known as CONMED Foot and Ankle, and Biorez, maker of the BioBrace reinforced implant for soft-tissue repair.

Implants, imagery and congresses.

Orthopaedic device makers sell to a narrow, expert audience: surgeons, theatre teams, hospital buyers and the distributors who serve them. Their brand material is shaped by that audience. Product imagery tends to be precise and technical, with implants rendered as clean metallic objects, often lit against dark or neutral backgrounds so that the form of a stem, a plate or a screw reads clearly.

Clinical imagery sits alongside the renders. X-rays, bone models, anatomical cut-aways and diagrams of a joint or a spinal segment show where a device goes and how it is meant to fit. Many makers also photograph surgeons in theatre, in gowns and masks under surgical lights, and show the trays of instruments that accompany an implant system, laid out in rows that suggest order and completeness.

Education is a large part of the picture. Device makers run training courses, cadaver labs and online technique guides, and much of their visual output is instructional: step-by-step surgical technique documents, animations and videos. Congresses matter too. Large meetings such as the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) and the congress of the European Federation of National Associations of Orthopaedics and Traumatology (EFORT) are where new systems are often shown, on stands designed to carry a brand at scale.

Corporate identities in the field are usually restrained: sans-serif wordmarks, a small set of brand colours and a great deal of white space, with the visual drama left to the product and the clinical image. Many brands also sit inside larger groups, so a single name may appear alongside a parent company’s mark. That makes the typeface, the palette and the treatment of imagery the main tools a maker has for being recognised.

From Utica to Largo.

The company writes its name in capitals — CONMED — and for five decades kept its headquarters in Utica. That changed in July 2022, when the head office moved to Largo, Florida, English Wikipedia says, citing the Utica Observer-Dispatch. The company says Utica was not left behind: it still manufactures there. Today it describes itself as having around 4,000 people in more than 20 locations, with manufacturing in the United States and Mexico and teams in Europe, Asia, Australia, Latin America and the Middle East.

Leadership has passed beyond the founding family. Wikipedia records that Eugene Corasanti led the company as chief executive until 2006; Curt Hartman became president, chief executive and chairman in 2014; and Pat Beyer became president and chief executive on 1 January 2025. CONMED is a publicly traded company.

Its own product pages group the range into orthopaedics and sports medicine — implants and suture anchors, fluid management and resection, surgical imaging and power tools, total joint and foot and ankle — and general, laparoscopic and robotic surgery, with electrosurgical units and smoke evacuation, alongside patient-monitoring items that go back to the original electrode business, such as ECG electrodes and the Hyfrecator 2000. Its marketing leans on the people in the operating theatre rather than the hardware: the history page talks about the surgical team, the athlete back on the field and the patient going home.

For a design guide, CONMED shows how a company built by acquisition can hold many product names — Hall, AirSeal, Y-Knot, BioBrace — under a single capitalised mark. Compare Smith+Nephew, another maker of sports medicine and arthroscopy equipment, and Arthrex. For this guide we use a navy, a teal and an instrument grey with a sans, an unofficial interpretation; no product or logo is reproduced.

Keep CONMED’s identity on hand — save it to a board in the Made Good inspiration library.